Barclays’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10	Closed	–	–	4472
2024 Q3	$0	Buy	+10	New	–	﹤0.01%	4417
2023 Q2	–	Sell	-5	Closed	–	–	4388
2023 Q1	$0	Buy	+5	New	–	﹤0.01%	4392